Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

When it comes to losing fat without extreme exercise, only a few medicines are worth considering. With the innovation in the medical world, physicians are now recommending the Ozempic weight loss ...

If you can’t or don’t want to take Ozempic, your healthcare professional may recommend a different medication. Rybelsus is a glucagon-like peptide-1 (GLP-1) receptor agonist medication that ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1.

Weight-loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists include Ozempic, Mounjaro, Wegovy and Zepbound—and they can be prescribed for obesity or type 2 diabetes.

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...

How does Ozempic work? Well, semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist ... It found that doses of 5 milligrams (mg), 10 milligrams and 15 milligrams led to weight loss.